Recent Quotes (30 days)

You have no recent quotes
chg | %

Clinigen Group PLC  

(Public, LON:CLIN)   Watch this stock  
-1.28 (-0.18%)
Sep 4 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 704.50 - 713.00
52 week 425.00 - 773.50
Open 710.00
Vol / Avg. 106,804.00/245,808.00
Mkt cap 777.53M*
P/E 36.35
Div/yield 1.10/0.45*
EPS 0.19*
Shares 109.71M
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 10.48% 12.80%
Operating margin 13.73% 16.99%
EBITD margin - 21.18%
Return on average assets 14.91% 17.66%
Return on average equity 21.66% 27.65%
Employees 107 -
CDP Score - -


Pitcairn House Crown Square, First Avenue
United Kingdom - Map
+44-1283-495010 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Clinigen Group plc (Clinigen) is a United-kingdom specialty pharmaceuticals and services business company. It operates in three segments: Clinical Trial Supply, Specialty Pharmaceuticals and Global Access Programs. Clinical Trial Supply (Clinigen CTS) sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies. Specialty Pharmaceuticals (Clinigen SP) manufactures and distributes its own and in-licensed specialist, hospital-only medicines across the world. Global Access Programs (Clinigen GAP) specializes in the consultancy, development, management and implementation of global access programs for biotechnology and pharmaceutical companies. It has added two oncology support products with the acquisition of Savene and Ethyol, together with Cardioxane bringing this portfolio to three and with the two anti-infectives (Foscavir and Vibativ), the total portfolio to five.

Officers and directors

Peter Lutz George Chief Executive Officer, Director
Martin James Abell Chief Financial Officer - Elect, Director
Age: 41
Shaun Edward Chilton Chief Operating Officer, Director
Age: 45
Paul Thomas Chief Technical Officer
Robin Andrew John Sibson Secretary, Non-Executive Director
Peter Vance Allen Independent Non-Executive Chairman of the Board
Age: 58
John Hartup Independent Non-Executive Director
Ian J. Nicholson MBA Independent Non-Executive Director